Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Alain Michel Insider Profile
4 Followers
Alain Michel, Director at DiagnoCure, holds 2.00K shares in RONA INC (Ticker: RONAF), holds 69.26K shares in DiagnoCure (Ticker: DGCRF). Most recently, Alain Michel Bought ― shares of RONA INC on Feb 28, 2012 for an estimated value of 94.65K.
Profitable Transactions
3 out of 4 Profitable Transactions
Average Return
+1.40%
Average return per transaction
Time Frame
Compare to
Insider Roles
Director
Roles that Alain Michel holds in companies
Most Profitable Insider Trade
Stock:
RONA INC
(RONAF)
(RONAF)
Rating:Informative Buy
Date:Feb 28, 2012 - Feb 28, 2013
Return:+22.80%
The most profitable trade made by Alain Michel
Alain Michel's Trading History
DiagnoCure
Dec 24, 2010
Director
Informative Buy
65.54K
$692.56
RONA INC
Feb 28, 2012
―
Informative Buy
94.65K
$37.09K
List of latest transactions for each holding click on a transaction to see Alain Michel's performance on stock
You May Also Like
Alain Michel insider profile FAQ
What is the percentage of profitable transactions made by Alain Michel?
The percentage of profitable transactions made by Alain Michel is 75%.
What is the average return per transaction made by Alain Michel?
The average return per transaction made by Alain Michel is 1.40%.
What stocks does Alain Michel hold?
Alain Michel holds: DGCRF, RONAF stocks.
What was Alain Michel’s latest transaction?
Alain Michel latest transaction was an Informative Buy of $94.65K.
What was Alain Michel's most profitable transaction?
Alain Michel’s most profitable transaction was an Informative Buy of RONAF stock on February 28, 2012. The return on the trade was 22.80%.
What is Alain Michel's role in DiagnoCure?
Alain Michel's role in DiagnoCure is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.